SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-030358
Filing Date
2019-05-17
Accepted
2019-05-17 21:29:48
Documents
1
Period of Report
2019-05-03

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3564
  Complete submission text file 0001104659-19-030358.txt   4871
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Issuer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 9 HOWELL DRIVE FAR HILLS NJ 07931
Business Address
Gionco David (Reporting) CIK: 0001456864 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35619 | Film No.: 19837465